Description
For Research Use Only
Ipamorelin is supplied exclusively for in vitro laboratory research. Not for human or
veterinary use. No dosing, reconstitution, administration or clinical guidance is provided.
This material is not a medicine and has not been assessed by any regulatory authority for
safety or efficacy. Purchase confirms the buyer is a qualified researcher.
Ipamorelin 10mg — Product Identity & Format
Ipamorelin is a synthetic pentapeptide and a selective agonist of the growth hormone
secretagogue receptor 1a (GHSR-1a), the receptor for ghrelin. It is supplied as a
lyophilised powder in a sealed 10mg vial for in vitro laboratory research.
Ipamorelin acts at a different receptor from the growth-hormone-releasing hormone
analogues in this category: GHSR-1a rather than GHRHR. That distinction is the reason the
two classes are studied both separately and in combination, and it is why this vial is
catalogued apart from the CJC-1295 blends.
Compound Identity
| Attribute | Value |
|---|---|
| INN / common name | Ipamorelin |
| CAS number | 170851-70-4 |
| Molecular formula | C38H49N9O5 |
| Molecular weight | 711.87 Da |
| Receptor target | GHSR-1a (ghrelin receptor) |
| Mechanism class | Ghrelin mimetic / GHSR-1a agonist |
| Supplied quantity | 10mg per vial |
| Physical form | Lyophilised powder |
Identity fields above are the specification published for this compound in the
Core Research catalogue. Confirm them against the batch-specific documentation for the
lot supplied before relying on them in experimental design.
Analytical Specification
Purity basis and threshold, appearance and storage condition for this SKU are being
confirmed and are not stated here until they are. No figure is estimated on this page:
an invented specification is worse than an absent one, because it cannot be reconciled
against a certificate.
Where a certificate exists for the lot supplied, request it against the lot identifier
printed on the container. See batch documentation.
Related Formats and Compounds
Ipamorelin is also supplied combined with CJC-1295 No DAC as a two-peptide preparation,
in vial, refill cartridge and pre-filled pen formats. The blend page carries the
comparative identity table for both components.
